The role of biopsy in the management of patients with presumed diffuse low grade glioma

Jansen NL, Graute V, Armbruster L et al (2012) MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET? Eur J Nucl Med Mol Imaging 39(6):1021–1029 Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79(4):533–536 Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 3(3):193–200 Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL (2010) Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol 96(1):11–16 Feiden W, Steude U, Bise K, Gundisch O (1991) Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14(1):51–56 Ranjan A, Rajshekhar V, Joseph T, Chandy MJ, Chandi SM (1993) Nondiagnostic CT-guided stereotactic biopsies in a series of 407 cases: influence of CT morphology and operator experience. J Neurosurg 79(6):839–844 Voges J, Schroder R, Treuer H et al (1993) CT-guided and computer assisted stereotactic biopsy. technique, results, indications. Acta Neurochir (Wien) 125(1–4):142–149 Arbit E, Galicich JH (1994) Importance of image-guided stereotactic biopsy to confirm diagnosis in an oncological setting. Ann Surg Oncol 1(5):368–372 Bernstein M, Parrent AG (1994) Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 81(2):165–168 Grunert P, Ungersbock K, Bohl J, Kitz K, Hopf N (1994) Results of 200 intracranial stereotactic biopsies. Neurosurg Rev 17(1):59–66 Levivier M, Goldman S, Pirotte B et al (1995) Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 82(3):445–452 Pirotte B, Goldman S, Bidaut LM et al (1995) Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir (Wien) 134(1–2):79–82 Goldman S, Levivier M, Pirotte B et al (1996) Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78(5):1098–1106 Krieger MD, Chandrasoma PT, Zee CS, Apuzzo ML (1998) Role of stereotactic biopsy in the diagnosis and management of brain tumors. Semin Surg Oncol 14(1):13–25 Kulkarni AV, Guha A, Lozano A, Bernstein M (1998) Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89(1):31–35 Sawin PD, Hitchon PW, Follett KA, Torner JC (1998) Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 49(6):640–649 Barnett GH, Miller DW, Weisenberger J (1999) Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases. J Neurosurg 91(4):569–576 Kondziolka D, Lunsford LD (1999) The role of stereotactic biopsy in the management of gliomas. J Neurooncol 42(3):205–213 Fontaine D, Dormont D, Hasboun D et al (2000) Magnetic resonance-guided stereotactic biopsies: results in 100 consecutive cases. Acta Neurochir 142(3):249–255; discussion 255–256 Massager N, David P, Goldman S et al (2000) Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 93(6):951–957 Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford LD (2001) Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94(4):545–551 Kaakaji W, Barnett GH, Bernhard D, Warbel A, Valaitis K, Stamp S (2001) Clinical and economic consequences of early discharge of patients following supratentorial stereotactic brain biopsy. J Neurosurg 94(6):892–898 Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ (2001) The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir 143(6):539–545; discussion 545–546 Paleologos TS, Dorward NL, Wadley JP, Thomas DG (2001) Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases. Neurosurgery 49(4):830–835; discussion 835–837 Ulm AJ, Bova FJ, Friedman WA (2001) Stereotactic biopsy aided by a computer graphics workstation: experience with 200 consecutive cases. Surg Neurol 56(6):366–371; discussion 371–372 Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y (2002) Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 97(2):354–362 Bhardwaj RD, Bernstein M (2002) Prospective feasibility study of outpatient stereotactic brain lesion biopsy. Neurosurgery 51(2):358–361; discussion 361–364 Dorward NL, Paleologos TS, Alberti O, Thomas DG (2002) The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 16(2):110–118 Kim JE, Kim DG, Paek SH, Jung HW (2003) Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir 145(7):547–554; discussion 554–555 Seliem RM, Assaad MW, Gorombey SJ, Moral LA, Kirkwood JR, Otis CN (2003) Fine-needle aspiration biopsy of the central nervous system performed freehand under computed tomography guidance without stereotactic instrumentation. Cancer 99(5):277–284 Pirotte B, Goldman S, Massager N et al (2004) Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 45(8):1293–1298 Aker FV, Hakan T, Karadereler S, Erkan M (2005) Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology 25(3):207–213 Grossman R, Sadetzki S, Spiegelmann R, Ram Z (2005) Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir 147(6):627–631; discussion 631 Hemm S, Rigau V, Chevalier J et al (2005) Stereotactic coregistration of 201Tl SPECT and MRI applied to brain tumor biopsies. J Nucl Med 46(7):1151–1157 Heper AO, Erden E, Savas A et al (2005) An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 64(Suppl 2):S82–S88 Hertel F, Feiden W, Bettag M (2005) The value of micro-Doppler in stereotactic brain biopsy. Minim Invasive Neurosurg 48(3):165–168 Maia AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol 26(4):777–783 McGirt MJ, Woodworth GF, Coon AL et al (2005) Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 102(5):897–901 Smith JS, Quinones-Hinojosa A, Barbaro NM, McDermott MW (2005) Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neurooncol 73(2):173–179 Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD (2006) Stereotactic biopsy of brain stem masses: decision analysis and literature review. Surg Neurol 66(5):484–490 Woodworth GF, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD (2006) Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique. J Neurosurg 104(2):233–237 Popperl G, Kreth FW, Mehrkens JH et al (2007) FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 34(12):1933–1942 Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ (2008) Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien) 150(1):23–29 Kongkham PN, Knifed E, Tamber MS, Bernstein M (2008) Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci 35(1):79–84 Lunsford LD, Niranjan A, Khan AA, Kondziolka D (2008) Establishing a benchmark for complications using frame-based stereotactic surgery. Stereotact Funct Neurosurg 86(5):278–287 Stockhammer F, Plotkin M, Amthauer H, van Landeghem FK, Woiciechowsky C (2008) Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neurooncol 88(2):205–210 Air EL, Leach JL, Warnick RE, McPherson CM (2009) Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases. J Neurosurg 111(4):820–824 Rachinger W, Grau S, Holtmannspotter M, Herms J, Tonn JC, Kreth FW (2009) Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry 80(10):1134–1139 Dammers R, Schouten JW, Haitsma IK, Vincent AJ, Kros JM, Dirven CM (2010) Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Acta Neurochir (Wien) 152(11):1915–1921 Meyer M, Keith-Rokosh J, Reddy H, Megyesi J, Hammond RR (2010) Sources of error in neuropathology intraoperative diagnosis. Can J Neurol Sci 37(5):620–624 Shooman D, Belli A, Grundy PL (2010) Image-guided frameless stereotactic biopsy without intraoperative neuropathological examination. J Neurosurg 113(2):170–178 Weber MA, Henze M, Tuttenberg J et al (2010) Biopsy targeting gliomas: do functional imaging techniques identify similar target areas? Invest Radiol 45(12):755–768 Amin DV, Lozanne K, Parry PV, Engh JA, Seelman K, Mintz A (2011) Image-guided frameless stereotactic needle biopsy in awake patients without the use of rigid head fixation. J Neurosurg 114(5):1414–1420 Ersahin M, Karaaslan N, Gurbuz MS et al (2011) The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique. Turkish Neurosurg 21(4):582–590 Kunz M, Thon N, Eigenbrod S et al (2011) Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas. Neuro Oncol. 13(3):307–316 Quinn J, Spiro D, Schulder M (2011) Stereotactic brain biopsy with a low-field intraoperative magnetic resonance imager. Neurosurgery 68(1 Suppl Operative):217–224; discussion 224 Bekelis K, Radwan TA, Desai A, Roberts DW (2012) Frameless robotically targeted stereotactic brain biopsy: feasibility, diagnostic yield, and safety. J Neurosurg 116(5):1002–1006 Christoforidis GA, Ming Yang M, Amir Abduljalil P et al (2012) “Tumoral Pseudoblush” identified within gliomas at high-spatial-resolution ultrahigh-field-strength gradient-echo MR imaging corresponds to microvascularity at stereotactic biopsy. Radiology 264(1):8 Dellaretti M, Reyns N, Touzet G et al (2012) Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90(2):79–83 Dellaretti M, Touzet G, Reyns N et al (2012) Correlation between magnetic resonance imaging findings and histological diagnosis of intrinsic brainstem lesions in adults. Neuro Oncol. 14(3):381–385 Gempt J, Buchmann N, Ryang YM et al (2012) Frameless image-guided stereotaxy with real-time visual feedback for brain biopsy. Acta Neurochir (Wien) 154(9):1663–1667 Lefranc M, Monet P, Desenclos C et al (2012) Perfusion MRI as a neurosurgical tool for improved targeting in stereotactic tumor biopsies. Stereotact Funct Neurosurg 90(4):240–247 Frati A, Pichierri A, Bastianello S et al (2011) Frameless stereotactic cerebral biopsy: our experience in 296 cases. Stereotact Funct Neurosurg 89(4):234–245 Woodworth G, McGirt MJ, Samdani A, Garonzik I, Olivi A, Weingart JD (2005) Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 27(4):358–362